期刊文献+

miR-221/222表达与甲状腺癌临床病理特征的关系 被引量:3

Correlation research on miR-221/222 expression and the pathological features of thyroid carcinomas
原文传递
导出
摘要 目的 了解miR-221/222在甲状腺癌组织中的表达情况,探讨miR-221/222表达与甲状腺癌临床病理特征的相关性.方法 收集杭州师范大学附属医院2013年3月至2014年2月行甲状腺切除手术的156例甲状腺组织标本.采用定量PCR检测miR-221/222在不同甲状腺组织中的表达,并对不同临床病理特征甲状腺癌组织miR-221/222表达水平进行对比分析.结果 经方差分析,miR-221/222表达水平在甲状腺癌组织与非癌组织间差异有统计学意义(F=9.358,P=0.0014).非癌组织之间miR-221/222表达差异无统计学意义(F=1.367,P=0.839).经Mann-Whitney U检验,miR-221/222在甲状腺腺外浸润、淋巴结转移、UICC分期不同病理特征甲状腺癌组织中表达水平差异有统计学意义(P<0.05).结论 miR-221/222在甲状腺癌组织中表达上调,表达水平与甲状腺癌临床病理特征有关,miR-221/222对于甲状腺癌的术前诊断、治疗及预后具有重要临床指导意义. Objective To explore the correlation between miR-221/222 expression and the pathological features of thyroid carcinomas.Methods A total of thyroid tissue specimens was collected in thyroid surgery from Mar 2013 to Feb 2014.The expression levels of miR-221/222 were tested with quantitative real-time polymerase chain reaction (RT-PCR).The expression levels of miR-221/222 were analyzed in different thyroid carcinoma tissues.Results The expression levels of miR-221/222 were significantly over-expressed in thyroid carcinoma tissues compared to non-thyroid carcinoma tissues (F =9.358,P =0.0014).No significant difference was found among different groups of non-thyroid carcinoma tissues (F =1.367,P =0.839).The expression levels of miR-221/222 were significantly different in thyroid carcinoma specimens with different pathological features (P 〈 0.05).Conclusions The expression levels of miR-221/222 were significantly over-expressed in thyroid carcinoma tissues.Both expression levels of miR221/222 were associated with extrathyroidal invasion,regional lymph nodes,and tumor staging.The expression levels of miR-221/222 might guide diagnosis,treatment,and prognosis of thyroid carcinomas.
作者 李丹 郑高明
出处 《中国医师杂志》 CAS 2015年第7期981-983,共3页 Journal of Chinese Physician
关键词 甲状腺肿瘤/代谢/病理学 微RNAs/代谢 Thyroid neoplasms/ME MicroRNAs/ME
  • 相关文献

参考文献9

  • 1杨靖,钟警,文格波.甲状腺癌相关microRNA[J].国际病理科学与临床杂志,2012,32(1):80-83. 被引量:1
  • 2Schaefer A, Jung M, Mollenkopf HJ, et al. Diagnostic and prog- nostic implications of microRNA profiling in prostate carcinoma [J]. Int J Cancer, 2010, 126(5) : 1166-1176.
  • 3Gramantieri L, Fornari F, Ferracin M, et al. MicroRNA-221 tar- gets Bmf in hepatocellular carcinoma and correlates with tumor multifocality [ J]. C/in Cancer Res, 2009, 15(16) : 5073-5081.
  • 4陈晓敏,曹国平,陈琪.miR-221及miR-222在甲状腺结节针吸细胞活检组织中的表达水平[J].现代实用医学,2013,25(10):1120-1122. 被引量:4
  • 5许践刚,黄关立,颜育祥,张宪波,胡晓清,赵挺,张筱骅.miR-221/miR-222在乳腺浸润性导管癌中的表达及临床意义[J].温州医学院学报,2010,40(1):27-31. 被引量:8
  • 6Brase JC, Johannes M, Schomn T, et al. Circulating miRNAs are correlated with tumor progression in prostate cancer [ J ]. Int J Cancer, 2011, 128(3): 608-616.
  • 7Spahn M, Kneitz S, Scholz C J, et al. Expression of microRNA- 221 is progressively reduced in aggressive prostate cancer and me- tastasis and predicts clinical recurrence [ J]. Int J Cancer, 2010, 127(2) : 394-403.
  • 8Quintavalle C, Garofalo M, Zanca C, et al. miR-221/222 over expression in human glioblastoma increases invasiveness by targe- ting the protein phosphate PTP [J]. Oncogene , 2012, 31 (7) : 858-868.
  • 9Chou CK, Chen RF, Chou FF, et al. miR-146b is highly ex- pressed in adult papillary thyroid carcinomas with high risk fea- tures including extrathymidal invasion and the BRAF ( V6OOE ) mutation[J]. Thyroid, 2010, 20(5): 489-894.

二级参考文献51

  • 1廖荣霞,孙建国,张亮,陈敏,陈彬,娄桂予,周度金,陈正堂.乳腺癌miRNAs表达谱检测及初步分析[J].第三军医大学学报,2006,28(22):2209-2212. 被引量:11
  • 2Ambros V. The functions of animal microRNAs[J]. Nature, 2004, 431(7006):350-355.
  • 3Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004,116(2):281 -297.
  • 4Plasterk,RH.Micro RNAs in animal development[J]. Cell, 2006,124(5):877-881.
  • 5Poy MN,Spranger M, Stoffel M. microRNAs and the regulation of glucose and lipid metabolism[J]. Diabetes Obes Metab, 2007,9(Suppl 2):67-73.
  • 6Chen CZ. MicroRNAs as oncogenes and tumor suppressors [J]. N Engl J Med, 2005, 353(17):1768-1771.
  • 7Fornari F, Gramantieri L, Ferracin M, et al. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma[J]. Oncogene, 2008,27(43): 5651-5661.
  • 8Galardi S, Mercatelli N, Giorda E, et al. miR-221 and miR- 222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1 [J]. Biol Chem, 2007, 282(32):23716-23724.
  • 9Visone R, Russo L, Pallante P, et al. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle[J]. Endocr Relat Cancer, 2007,14(3):791-798.
  • 10Gramantieri L, Fornari F, Ferracin M, et al.MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality[J]. Clin Cancer Research, 2009, 15(16): 5073-5081.

共引文献10

同被引文献33

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部